Private Equity

Updated:

Maxis

MAXIS is a development company founded in 2003 in San Jose, California. It specializes in clinical research, market development, pre-engineering, and...

Maxis logo

Maxis

MAXIS is a development company founded in 2003 in San Jose, California. It specializes in clinical research, market development, pre-engineering, and regulatory submissions for medical device technologies. MAXIS was acquired by Avania in February 2023.

General information

Firm type

Private Equity

Year founded

2007

AUM

Undisclosed

Location

Region

Middle East

Country

Turkey

City

Greenwich

Corporate office

Turkey

Frequently asked questions

What investment stages does Maxis target across its funds?

Maxis operates a fund family that spans the full Turkish venture lifecycle, from pre-seed to late-stage growth and restructuring. The firm's website highlights a commitment to early-stage investments in future solutions while also maintaining vehicles for expansion capital and balance-sheet restructuring. The Atlas Büyüme Sermayesi fund, for example, executed a growth-stage transaction in the branded consumer sector in late 2025.

How is Maxis's fund platform structured?

The firm organizes its capital under a 'fund ecosystem' model with distinct strategies for early-stage venture, growth equity, and restructuring. This architecture allows Maxis to support companies from pre-seed formation through to late-stage growth and special situations. Specific named vehicles include the Atlas Büyüme Sermayesi (Atlas Growth Capital) fund.

Does Maxis co-invest alongside external partners on direct deals?

Yes. A publicly disclosed transaction in late 2025 involved a co-investment alongside Mada, a Turkish investment office, to back the luxury perfume house Nishane through Maxis's growth capital fund. The firm's model accommodates syndicated direct investments.

What is the firm's approach to portfolio company operations?

Maxis articulates a three-pillar operational engagement model: strategic guidance, development of management and operations, and effective balance-sheet management. This suggests the team takes an active role in shaping governance and finance functions, rather than serving as a passive capital provider.

Does the firm maintain an impact or ESG mandate?

Maxis has received external recognition for impact orientation from the Arya Women Investment Platform, which named it the 'Most Impact-Focused Portfolio Management Company' at its 2025 gala. The firm's public messaging emphasizes sustainable support for society and the environment, though a formal ESG policy document has not been published.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Greenwich Private Equity profiles